• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PSK在远处部位的抗肿瘤作用:小鼠肿瘤中白细胞介素-8样因子和巨噬细胞趋化因子的诱导

Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.

作者信息

Ebina T, Murata K

机构信息

Department of Bacteriology, Tohoku University School of Medicine, Sendai.

出版信息

Jpn J Cancer Res. 1990 Dec;81(12):1307-13. doi: 10.1111/j.1349-7006.1990.tb02695.x.

DOI:10.1111/j.1349-7006.1990.tb02695.x
PMID:2126000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918000/
Abstract

The antitumor effect of PSK, a Coriolus preparation, at a distant site was analyzed with the use of a double grafted tumor system in which male BALB/c mice received simultaneous intradermal inoculations of Meth-A tumor in the right (10(6) cells) and the left (2 x 10(5) cells) flanks and were then injected with PSK in the right tumor on the third day thereafter. The antitumor effect of intratumoral administration of PSK in the right tumor on days 3, 4 and 5 was compared with the effect of surgical resection of the right tumor on day 5. Three out of 8 mice given PSK intratumorally became tumor-free whereas no mouse tumor-free in the left flank was found among the surgically resected mice. As regards sinecomitant immunity, tumor inoculation into the right flank followed by intra-tumoral administration of PSK on days 3 and 5 and surgical excision of the primary tumor on day 6 resulted in complete rejection of a tumor challenge in the left flank on day 21. The combination of presurgical intratumoral injections of PSK (more than 2 times) and postoperative oral administration of PSK appeared to be most effective in eradicating secondary tumors. Isolated TILs (tumor-infiltrating lymphocytes), obtained from the right tumor (treated with PSK) and the left tumor on day 10 in the double grafted tumor system were cultured in RPMI1640 with 10% fetal calf serum for 24 h. The culture supernatants were harvested and tested for the presence of chemotactic activity for neutrophils or macrophages. Significant neutrophil chemotactic factor (NCF) and macrophage chemotactic factor (MCF) activities were detected in the culture media from PSK-treated TILs that had been cultured for 24 h. Neither significant neutrophil nor macrophage chemotactic activity was detected in the media from untreated TILs. NCF and MCF activities were also detected in the culture supernatant from PSK-treated tumor tissue on day 6. PSK-induced NCF in the murine tumor was neutralized by treatment with anti-human IL-8 IgG, and might be murine IL-8-like factor. Therefore, neutrophil and macrophage infiltrations of tumors following intratumoral injections of PSK are probably mediated by inductions of IL-8-like factor and MCF.

摘要

使用双移植肿瘤系统分析了云芝提取物PSK在远处部位的抗肿瘤作用,该系统中雄性BALB/c小鼠在右侧(10⁶个细胞)和左侧(2×10⁵个细胞)胁腹同时进行皮内接种Meth-A肿瘤,然后在第三天给右侧肿瘤注射PSK。将右侧肿瘤在第3、4和5天瘤内注射PSK的抗肿瘤作用与第5天手术切除右侧肿瘤的作用进行比较。8只瘤内注射PSK的小鼠中有3只无瘤,而手术切除的小鼠中左侧胁腹未发现无瘤小鼠。关于伴随免疫,在右侧胁腹接种肿瘤,然后在第3天和第5天进行瘤内注射PSK,并在第6天手术切除原发肿瘤,导致在第21天左侧胁腹的肿瘤攻击被完全排斥。术前瘤内注射PSK(超过2次)与术后口服PSK的联合似乎在根除继发性肿瘤方面最有效。在双移植肿瘤系统中,于第10天从右侧肿瘤(用PSK处理)和左侧肿瘤获得的分离肿瘤浸润淋巴细胞(TILs)在含10%胎牛血清的RPMI1640中培养24小时。收集培养上清液并检测对中性粒细胞或巨噬细胞的趋化活性。在培养24小时的PSK处理的TILs的培养基中检测到显著的中性粒细胞趋化因子(NCF)和巨噬细胞趋化因子(MCF)活性。在未处理的TILs的培养基中未检测到显著的中性粒细胞或巨噬细胞趋化活性。在第6天PSK处理的肿瘤组织的培养上清液中也检测到NCF和MCF活性。用抗人IL-8 IgG处理可中和PSK在鼠肿瘤中诱导的NCF,其可能是鼠IL-8样因子。因此,瘤内注射PSK后肿瘤的中性粒细胞和巨噬细胞浸润可能是由IL-8样因子和MCF的诱导介导的。

相似文献

1
Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.PSK在远处部位的抗肿瘤作用:小鼠肿瘤中白细胞介素-8样因子和巨噬细胞趋化因子的诱导
Jpn J Cancer Res. 1990 Dec;81(12):1307-13. doi: 10.1111/j.1349-7006.1990.tb02695.x.
2
[Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
Gan To Kagaku Ryoho. 1991 Aug;18(11):1812-6.
3
Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.PSK的抗肿瘤作用:区域淋巴结的作用以及对小鼠伴随免疫和伴随性免疫的增强
Jpn J Cancer Res. 1989 Feb;80(2):158-66. doi: 10.1111/j.1349-7006.1989.tb02284.x.
4
Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.蛋白结合多糖制剂PSK双移植瘤系统中远处位点的抗肿瘤效应机制
Jpn J Cancer Res. 1988 Aug;79(8):957-64. doi: 10.1111/j.1349-7006.1988.tb00061.x.
5
[Differences of antitumor effect of various BRMs by intratumoral administration].[不同生物反应调节剂瘤内注射的抗肿瘤效果差异]
Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1429-32.
6
Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.白细胞介素-1β在双移植瘤系统远处位点的抗肿瘤效应机制
Jpn J Cancer Res. 1991 Nov;82(11):1292-8. doi: 10.1111/j.1349-7006.1991.tb01795.x.
7
Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.PSK在远处位点的抗肿瘤作用:肿瘤特异性免疫以及与其他化疗药物的联合应用
Jpn J Cancer Res. 1992 Jul;83(7):775-82. doi: 10.1111/j.1349-7006.1992.tb01979.x.
8
[Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 1):1847-53.
9
[Antitumor effect of PSK (1). Interferon-inducing activity and intratumoral administration].[PSK的抗肿瘤作用(1)。干扰素诱导活性及瘤内给药]
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 1):1841-6.
10
[Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].[瘤内给药时各种生物反应调节剂的抗肿瘤效果差异:免疫抑制酸性蛋白的诱导]
Gan To Kagaku Ryoho. 1993 Aug;20(11):1453-6.

引用本文的文献

1
Circulating promyelocytes and low levels of CD16 expression on polymorphonuclear leukocytes accompany early-onset periodontitis.循环早幼粒细胞以及多形核白细胞上低水平的CD16表达与早发性牙周炎相伴。
Infect Immun. 1997 Sep;65(9):3906-12. doi: 10.1128/iai.65.9.3906-3912.1997.
2
Antitumor effect of intratumoral administration of biological response modifiers: induction of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in mice.瘤内注射生物反应调节剂的抗肿瘤作用:小鼠体内免疫抑制酸性蛋白(一种α1-酸性糖蛋白)的诱导
Jpn J Cancer Res. 1994 Jan;85(1):93-100. doi: 10.1111/j.1349-7006.1994.tb02891.x.
3
Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901.对口服给予抗肿瘤多糖SPR-901的小鼠中针对小鼠同基因肿瘤MethA的效应T细胞的分析。
Cancer Immunol Immunother. 1994 Mar;38(3):143-8. doi: 10.1007/BF01525634.
4
Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.PSK在远处位点的抗肿瘤作用:肿瘤特异性免疫以及与其他化疗药物的联合应用
Jpn J Cancer Res. 1992 Jul;83(7):775-82. doi: 10.1111/j.1349-7006.1992.tb01979.x.

本文引用的文献

1
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.一种与其他宿主防御细胞因子具有肽序列相似性的人单核细胞衍生嗜中性粒细胞趋化因子的纯化。
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9233-7. doi: 10.1073/pnas.84.24.9233.
2
Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).脂多糖(LPS)刺激的人血单核白细胞产生的中性粒细胞趋化因子:部分特性及与白细胞介素1(IL-1)的分离
J Immunol. 1987 Aug 1;139(3):788-93.
3
Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.人单核细胞衍生的中性粒细胞趋化因子(MDNCF)的分子克隆以及白细胞介素1和肿瘤坏死因子对MDNCF mRNA的诱导作用
J Exp Med. 1988 Jun 1;167(6):1883-93. doi: 10.1084/jem.167.6.1883.
4
Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.蛋白结合多糖制剂PSK双移植瘤系统中远处位点的抗肿瘤效应机制
Jpn J Cancer Res. 1988 Aug;79(8):957-64. doi: 10.1111/j.1349-7006.1988.tb00061.x.
5
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice.具有不同巨噬细胞含量及在裸鼠中致瘤性的人黑色素瘤细胞系中的趋化因子及P15E相关趋化抑制因子
J Immunol. 1987 Apr 1;138(7):2372-9.
6
Antimetastatic effect of biological response modifiers in the "double grafted tumor system".
Jpn J Cancer Res. 1986 Oct;77(10):1034-42.
7
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.一种由人骨髓单核细胞系产生的新型单核细胞趋化和激活因子的纯化与特性分析
J Exp Med. 1989 Apr 1;169(4):1485-90. doi: 10.1084/jem.169.4.1485.
8
Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF).人单核细胞趋化激活因子(MCAF)cDNA的克隆与测序
Biochem Biophys Res Commun. 1989 Feb 28;159(1):249-55. doi: 10.1016/0006-291x(89)92430-3.
9
Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.人单核细胞衍生的中性粒细胞趋化因子白细胞介素-8的基因组结构。
J Immunol. 1989 Aug 15;143(4):1366-71.
10
The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.中性粒细胞激活蛋白(NAP-1)对T淋巴细胞也具有趋化作用。
Science. 1989 Mar 17;243(4897):1464-6. doi: 10.1126/science.2648569.